236 related articles for article (PubMed ID: 11369759)
1. CCAAT/enhancer-binding protein-alpha cooperates with p21 to inhibit cyclin-dependent kinase-2 activity and induces growth arrest independent of DNA binding.
Harris TE; Albrecht JH; Nakanishi M; Darlington GJ
J Biol Chem; 2001 Aug; 276(31):29200-9. PubMed ID: 11369759
[TBL] [Abstract][Full Text] [Related]
2. p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity.
Fotedar R; Fitzgerald P; Rousselle T; Cannella D; Dorée M; Messier H; Fotedar A
Oncogene; 1996 May; 12(10):2155-64. PubMed ID: 8668341
[TBL] [Abstract][Full Text] [Related]
3. A new pathway for mitogen-dependent cdk2 regulation uncovered in p27(Kip1)-deficient cells.
Coats S; Whyte P; Fero ML; Lacy S; Chung G; Randel E; Firpo E; Roberts JM
Curr Biol; 1999 Feb; 9(4):163-73. PubMed ID: 10074425
[TBL] [Abstract][Full Text] [Related]
4. A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breast cancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescence.
Carroll JS; Prall OW; Musgrove EA; Sutherland RL
J Biol Chem; 2000 Dec; 275(49):38221-9. PubMed ID: 10991938
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor inhibits chondrocytic growth through induction of p21 and subsequent inactivation of cyclin E-Cdk2.
Aikawa T; Segre GV; Lee K
J Biol Chem; 2001 Aug; 276(31):29347-52. PubMed ID: 11384971
[TBL] [Abstract][Full Text] [Related]
6. Dual cyclin-binding domains are required for p107 to function as a kinase inhibitor.
Castaño E; Kleyner Y; Dynlacht BD
Mol Cell Biol; 1998 Sep; 18(9):5380-91. PubMed ID: 9710622
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.
Orend G; Hunter T; Ruoslahti E
Oncogene; 1998 May; 16(20):2575-83. PubMed ID: 9632134
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle-dependent phosphorylation of p27 cyclin-dependent kinase (Cdk) inhibitor by cyclin E/Cdk2.
Morisaki H; Fujimoto A; Ando A; Nagata Y; Ikeda K; Nakanishi M
Biochem Biophys Res Commun; 1997 Nov; 240(2):386-90. PubMed ID: 9388487
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoids stimulate p21(CIP1) in mesangial cells and in anti-GBM glomerulonephritis.
Terada Y; Okado T; Inoshita S; Hanada S; Kuwahara M; Sasaki S; Yamamoto T; Marumo F
Kidney Int; 2001 May; 59(5):1706-16. PubMed ID: 11318941
[TBL] [Abstract][Full Text] [Related]
10. PKCeta associates with cyclin E/cdk2/p21 complex, phosphorylates p21 and inhibits cdk2 kinase in keratinocytes.
Kashiwagi M; Ohba M; Watanabe H; Ishino K; Kasahara K; Sanai Y; Taya Y; Kuroki T
Oncogene; 2000 Dec; 19(54):6334-41. PubMed ID: 11175348
[TBL] [Abstract][Full Text] [Related]
11. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
Chen IT; Akamatsu M; Smith ML; Lung FD; Duba D; Roller PP; Fornace AJ; O'Connor PM
Oncogene; 1996 Feb; 12(3):595-607. PubMed ID: 8637717
[TBL] [Abstract][Full Text] [Related]
12. Site-directed mutant p21 proteins defective in both inhibition of E2F-regulated transcription and disruption of E2F-p130-cyclin-cdk2 complexes.
Robles SJ; Shiyanov P; Aristodemo GT; Raychaudhuri P; Adami GR
DNA Cell Biol; 1998 Jan; 17(1):9-18. PubMed ID: 9468218
[TBL] [Abstract][Full Text] [Related]
13. Mutant p53 can delay growth arrest and loss of CDK2 activity in senescing human fibroblasts without reducing p21(WAF1) expression.
Wyllie F; Haughton M; Bartek J; Rowson J; Wynford-Thomas D
Exp Cell Res; 2003 May; 285(2):236-42. PubMed ID: 12706118
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells.
Gong J; Ammanamanchi S; Ko TC; Brattain MG
Cancer Res; 2003 Jun; 63(12):3340-6. PubMed ID: 12810668
[TBL] [Abstract][Full Text] [Related]
15. Caco-2 intestinal cell differentiation is associated with G1 arrest and suppression of CDK2 and CDK4.
Ding QM; Ko TC; Evers BM
Am J Physiol; 1998 Nov; 275(5):C1193-200. PubMed ID: 9814966
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
[TBL] [Abstract][Full Text] [Related]
17. Complete inhibition of Cdk/cyclin by one molecule of p21(Cip1).
Hengst L; Göpfert U; Lashuel HA; Reed SI
Genes Dev; 1998 Dec; 12(24):3882-8. PubMed ID: 9869641
[TBL] [Abstract][Full Text] [Related]
18. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
Prall OW; Sarcevic B; Musgrove EA; Watts CK; Sutherland RL
J Biol Chem; 1997 Apr; 272(16):10882-94. PubMed ID: 9099745
[TBL] [Abstract][Full Text] [Related]
19. The protein SET regulates the inhibitory effect of p21(Cip1) on cyclin E-cyclin-dependent kinase 2 activity.
Estanyol JM; Jaumot M; Casanovas O; Rodriguez-Vilarrupla A; Agell N; Bachs O
J Biol Chem; 1999 Nov; 274(46):33161-5. PubMed ID: 10551888
[TBL] [Abstract][Full Text] [Related]
20. A low abundance pool of nascent p21WAF1/Cip1 is targeted by estrogen to activate cyclin E*Cdk2.
Prall OW; Carroll JS; Sutherland RL
J Biol Chem; 2001 Nov; 276(48):45433-42. PubMed ID: 11581254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]